Production (Stage)
AxoGen, Inc.
AXGN
$11.07
$0.131.19%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 17.36% | 15.10% | 17.86% | 25.57% | 12.86% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 17.36% | 15.10% | 17.86% | 25.57% | 12.86% |
Cost of Revenue | 55.59% | 8.52% | 27.58% | 47.79% | 7.17% |
Gross Profit | 7.09% | 17.34% | 14.93% | 19.20% | 14.49% |
SG&A Expenses | 2.46% | 2.90% | 2.49% | -1.00% | 0.89% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 9.32% | 2.76% | 8.09% | 7.29% | 4.39% |
Operating Income | 63.57% | 163.15% | 92.15% | 93.80% | 37.88% |
Income Before Tax | 42.22% | 111.56% | 54.56% | 71.16% | 6.21% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 42.22% | 111.56% | 54.56% | 71.16% | 6.21% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 42.22% | 111.56% | 54.56% | 71.16% | 6.21% |
EBIT | 63.57% | 163.15% | 92.15% | 93.80% | 37.88% |
EBITDA | 104.50% | 335.76% | 150.05% | 121.63% | 54.61% |
EPS Basic | 44.76% | 111.06% | 55.47% | 71.75% | 7.64% |
Normalized Basic EPS | 44.73% | 111.15% | 55.39% | 71.68% | 7.70% |
EPS Diluted | 44.76% | 111.06% | 57.70% | 72.56% | 9.71% |
Normalized Diluted EPS | 44.73% | 110.44% | 55.39% | 71.68% | 7.70% |
Average Basic Shares Outstanding | 4.56% | 4.24% | 2.00% | 1.99% | 1.56% |
Average Diluted Shares Outstanding | 4.56% | 11.65% | 2.00% | 1.99% | 1.56% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |